<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000604.v1.p1" parentStudy="phs000604.v1.p1" createDate="2013-03-11" modDate="2013-05-30">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Julie A. Douglas, PhD</td><td>University of Michigan, Ann Arbor, MI, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Mark A. Helvie, MD</td><td>University of Michigan, Ann Arbor, MI, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Heang-Ping Chan, PhD</td><td>University of Michigan, Ann Arbor, MI, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Chuan Zhou, PhD</td><td>University of Michigan, Ann Arbor, MI, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Daniel McConnell, PhD</td><td>University of Michigan, Ann Arbor, MI, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Mapping Genes for Mammographic Density</StudyNameEntrez>
	<StudyNameReportPage>Mapping Genes for Mammographic Density</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Population</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>We recruited 1,521 women from the Old Order Amish (OOA) population of Lancaster County, Pennsylvania, with the primary goal of identifying genetic factors that influence mammographic density. All women were between the ages of 40 and 88 years, with a mean of 54 years. Additional study design details, including eligibility criteria, are described elsewhere (Douglas et al., <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19029399">2008</a>).</p> <p>The present-day OOA of Lancaster County are the descendants of approximately 550 individuals from central Western Europe who immigrated to the U.S. in the early eighteenth century. All living individuals derive from a single, 14-generation pedigree (Lee et al., <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20433770">2010</a>). Although the OOA are a genetically closed founder population, allele frequencies and LD profiles are remarkably similar between the OOA and U.S. participants in the International HapMap project (HapMap CEU) for common SNPs (MAF&gt;/=5%) (Van Hout et al., <a href="http://www.ncbi.nlm.nih.gov/pubmed?cmd=DetailsSearch&term=19697356[PMID]">2010</a>).</p> <p>We recently completed genome-wide linkage and association analyses of mammographic density, including dense and non-dense areas of the breast and the ratio of dense to total area of the breast. Summary-level data from our GWAS are available here and through the Marker of DEnsity (MODE) Consortium.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>All Old Order Amish women were eligible to participate if they were at least 40 years of age at the time of interview. Women were excluded if they were (1) pregnant or lactating in the previous 6 months, (2) had ever been diagnosed with breast or ovarian cancer, (3) had one or both ovaries removed, or (4) used exogenous sex steroid hormones in the previous 6 months.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="19029399"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18321883"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19697356"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20527563"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20175501"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23626830"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Neoplasm"/>
		<Disease vocab_source="MESH" vocab_term="Breast Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Julie A. Douglas, PhD</AttName>
			<Institution>University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Mark A. Helvie, MD</AttName>
			<Institution>University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Heang-Ping Chan, PhD</AttName>
			<Institution>University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Chuan Zhou, PhD</AttName>
			<Institution>University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Daniel McConnell, PhD</AttName>
			<Institution>University of Michigan, Ann Arbor, MI, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Alan R. Shuldiner, MD</AttName>
			<Institution>University of Maryland, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Braxton D. Mitchell, PhD</AttName>
			<Institution>University of Maryland, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>R01 CA122844</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
		<Header title="Genotyping Center">
			<AttName>Center for Inherited Disease Research (CIDR)</AttName>
			<Institution>Johns Hopkins University, Baltimore, MD, USA</Institution>
		</Header>
		<Header title="Genotyping Center Funding Source">
			<AttName>X01 HG005954</AttName>
			<Institution>National Institutes of Health, Bethesda, MD, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>no</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="100" shortName="Genotype_Analysis" longName="Genotype and Analysis"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NCI</DacName>
      <DacFullName>NCI</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000604.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000604.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000604.v1.p1" FileName="eNCI_0075_DUC_3.7.2013.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use (MDS)</ConsentName>
        <ConsentAbbrev>GRU-MDS</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.
Use of the data includes methods development research (e.g., development of software or algorithms).</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>

<Analyses>
	<Analysis pha="3604" genomeBuild="37" snpBuild="137" analysisType="">
		<Description>We conducted genome-wide association analyses of mammographic density, including dense and non-dense areas of the breast and the ratio of dense to total area of the breast.  The Center for Inherited Disease Research (CIDR) genotyped 2,443,179 SNPs using the Illumina HumanOmni2.5-4v1_B Array.  Summary-level data are based on 1,472 OOA women, including 723 pre- and 749 post-menopausal women, and the 1,452,421 SNPs that passed our quality-control filters and had a minor allele frequency of at least 1%.</Description>
		<Method>Quantitative trait analysis</Method>
		<GtyPlatform probeNum="2449998" snpBatchId="1056550">
			<Vendor>ILLUMINA</Vendor>
			<VendorURL>Snp Marker 2.5M</VendorURL>
			<Platform>ILLUMINA|HUMANOMNI2.5-4V1_B</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
	<Analysis pha="3605" genomeBuild="37" snpBuild="137" analysisType="">
		<Description>We conducted genome-wide association analyses of mammographic density, including dense and non-dense areas of the breast and the ratio of dense to total area of the breast.  The Center for Inherited Disease Research (CIDR) genotyped 2,443,179 SNPs using the Illumina HumanOmni2.5-4v1_B Array.  Summary-level data are based on 1,472 OOA women, including 723 pre- and 749 post-menopausal women, and the 1,452,421 SNPs that passed our quality-control filters and had a minor allele frequency of at least 1%.</Description>
		<Method>Quantitative trait analysis</Method>
		<GtyPlatform probeNum="2449998" snpBatchId="1056550">
			<Vendor>ILLUMINA</Vendor>
			<VendorURL>Snp Marker 2.5M</VendorURL>
			<Platform>ILLUMINA|HUMANOMNI2.5-4V1_B</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
	<Analysis pha="3606" genomeBuild="37" snpBuild="137" analysisType="">
		<Description>We conducted genome-wide association analyses of mammographic density, including dense and non-dense areas of the breast and the ratio of dense to total area of the breast.  The Center for Inherited Disease Research (CIDR) genotyped 2,443,179 SNPs using the Illumina HumanOmni2.5-4v1_B Array.  Summary-level data are based on 1,472 OOA women, including 723 pre- and 749 post-menopausal women, and the 1,452,421 SNPs that passed our quality-control filters and had a minor allele frequency of at least 1%.</Description>
		<Method>Quantitative trait analysis</Method>
		<GtyPlatform probeNum="2449998" snpBatchId="1056550">
			<Vendor>ILLUMINA</Vendor>
			<VendorURL>Snp Marker 2.5M</VendorURL>
			<Platform>ILLUMINA|HUMANOMNI2.5-4V1_B</Platform>
		</GtyPlatform>
		<Comment></Comment>
	</Analysis>
</Analyses>

</Study>

</Studies>

</GaPExchange>
